Process / pipelinehealthcare financial planning
Budget Impact Analysis (BIA)
Budget impact analysis estimates the financial consequences (net costs or savings) of implementing a new health technology in a specific healthcare system or population over a short time horizon (typically 1–5 years). Distinct from cost-effectiveness analysis (which compares health outcomes per dollar), BIA answers a budgetary question: 'If we adopt this new drug/device, how much will it cost our health system next year?' Widely used by hospital procurement committees, insurance formularies, and government health budgets to assess financial feasibility and reimbursement decision.
Apply with EconMindSoonVideoSoon
Read the full method
Members only
Sign inSign in with a free account to read this section.
Sources
- Sullivan, S. D., Mauskopf, J. A., Augustovski, F., et al. (2014). Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health, 17(1), 5-14. DOI: 10.1016/j.jval.2013.08.2291 ↗
- Klok, R. M., Brouwers, J. R., Postma, M. J., et al. (2005). Budget-impact analysis: a systematic literature review of implementation studies. The Annals of Pharmacotherapy, 39(3), 518-526. DOI: 10.1345/aph.1E337 ↗
- Canadian Agency for Drugs and Technologies in Health (CADTH). (2017). Guidelines for the Economic Evaluation of Health Technologies: Canada (4th ed.). Ottawa: CADTH. link ↗